Literature DB >> 1689678

A new approach to the management of malignant ascites; a permanently implanted abdominal drain.

M A Belfort1, P J Stevens, K DeHaek, R Soeters, J E Krige.   

Abstract

A new approach to the problem of intractable malignant ascites in preterminal abdominal carcinoma is presented. Seventeen patients treated with a new implantable silastic drain are described. Symptomatic relief was excellent in all patients for as long as the drain was patent. Complications included abdominal wall cellulitis in two instances and one case of peritonitis, but did not preclude continued drain function in 15 of the 17 cases. In eight of the 17 cases organisms were cultured from the ascitic fluid while the catheter was in situ. Drainage of ascitic fluid in this way appears to be a practical management for intractable malignant ascites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689678

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success.

Authors:  C R Tapping; L Ling; A Razack
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

2.  Peritoneal catheter for continuous drainage of ascites in advanced cancer patients.

Authors:  Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Ferrera; Patrizia Villari; Fabrizio David
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

Review 3.  Symptomatic Fluid Drainage: Tunneled Peritoneal and Pleural Catheters.

Authors:  Tony Ha; David C Madoff; David Li
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

Review 4.  Treatment of malignant ascites.

Authors:  Michael Chung; Peter Kozuch
Journal:  Curr Treat Options Oncol       Date:  2008-09-06

5.  Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome.

Authors:  Geert Maleux; Inge Indesteege; Annouschka Laenen; Chris Verslype; Ignace Vergote; Hans Prenen
Journal:  Radiol Oncol       Date:  2016-02-07       Impact factor: 2.991

Review 6.  Drainage of malignant ascites: patient selection and perspectives.

Authors:  Maciej Stukan
Journal:  Cancer Manag Res       Date:  2017-04-12       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.